Results 151 to 160 of about 44,922 (302)
Bacteriophage therapy is characterised by numerous advantages, facilitating its diverse aquaculture application and efficacy as an antibiotic alternative mitigating the spread of antimicrobial‐resistant pathogens. Contributing to the modern reappraisal of the aquaculture application of bacteriophage therapy, challenges impeding its widespread ...
Louise James +4 more
wiley +1 more source
Bacteriophage Therapy: Overcoming Antimicrobial Resistance Through Advanced Delivery Methods. [PDF]
Wacnik M +3 more
europepmc +1 more source
Bacteriophage Therapy: An Unforgetten Source of Cure
Aycan Gündoğdu, Ayşegül Ulu-Kılıç
openalex +1 more source
Cas9 beyond CRISPR – SUMOylation, effector‐like potential and pathogenic adaptation
This Viewpoint explores the possibility that Cas9, beyond its canonical role in CRISPR immunity, may act as a host‐modulating effector during infection by Cas9‐encoding bacteria. Such a nucleomodulin‐like function could be influenced by eukaryotic post‐translational modifications, particularly SUMOylation, with potential implications for host–pathogen ...
Umut Sahin
wiley +1 more source
Bacteriophage Interactions With Epithelial Cells: Therapeutic Implications
Andrzej Górski +6 more
doaj +1 more source
Bacteriophage Therapy in Selected Disease Entities: A Review of the Literature. [PDF]
Dudek A +6 more
europepmc +1 more source
Bacteriophage therapy in the critically ill [PDF]
Josephine Ho +4 more
openalex +1 more source
Bacterial Extracellular Vesicles in the Pathogenesis and Treatment of Liver Diseases
Liver diseases are a major global health challenge, with current treatments inadequate. This review highlights the role of bacterial extracellular vesicles in liver inflammation, fibrosis, and metabolism. We also explore these from commensals and probiotics, their protective effects, and discuss research challenges and future therapeutic potential ...
Yakun Li +3 more
wiley +1 more source
Bacteriophage Therapy: Discovery, Development, and FDA Approval Pathways. [PDF]
Niazi SK.
europepmc +1 more source

